FXTAS in Spanish Patients with Ataxia: Support for Female FMR1 Premutation Screening

被引:0
作者
Laia Rodriguez-Revenga
Beatriz Gómez-Anson
Esteban Muñoz
Dolores Jiménez
Monica Santos
Mar Tintoré
Gisela Martín
Luis Brieva
Montserrat Milà
机构
[1] Hospital Clínic,Biochemistry and Molecular Genetics Department
[2] IDIBAPS (Institut d’Investigacions Biomèdiques August Pi i Sunyer),Radiology Department, CDI
[3] Hospital Clínic,Neurology Service
[4] Hospital Clínic,Neurology Service
[5] Hospital Vall d’Hebrón,Neurology Service
[6] Hospital Verge de la Cinta,Neurology Service
[7] Hospital Arnau de Vilanova,undefined
来源
Molecular Neurobiology | 2007年 / 35卷
关键词
Fragile X-associated tremor/ataxia syndrome; FXTAS; premutation; Dominant spinocerebellar ataxia; Genetic screening;
D O I
暂无
中图分类号
学科分类号
摘要
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a newly described disorder characterized by progressive action tremor and ataxia that occurs in premutation carriers of the FMR1 gene. The incidence of FMR1 premutated carriers in the general population is relatively high, and therefore FXTAS might explain a considerable number of sporadic, late-onset ataxias. To better establish the prevalence of FXTAS among undiagnosed Spanish patients with ataxia, we have performed a FMR1 premutation screening. Our results evidenced three individuals carrying premutated alleles, giving an estimated FXTAS prevalence of 1.95% among patients with late-onset ataxia (1.15% for males and 3% for females). Molecular characterization of premutation carriers evidences lower fragile X mental retardation 1 protein levels and increased FMR1 mRNA levels. Clinical and neuroimaging findings support FXTAS diagnosis in these patients. Because of the high prevalence of FMR1 premutation in the general population, the description and characterization of the FXTAS syndrome is of great interest as it may represent one of the more common monogenic causes of ataxia, tremor, and dementia. The results obtained in this study demonstrate that FXTAS should be incorporated to spinocerebellar ataxia genetic screening protocols. Early diagnosis of these patients benefits not only them but also the rest of the family that should be advised for the fragile X syndrome.
引用
收藏
页码:324 / 328
页数:4
相关论文
共 54 条
[1]  
Fu YH(1991)Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox Cell 67 1047-1058
[2]  
Kuhl DP(1991)Absence of expression of the Cell 66 817-822
[3]  
Pizzuti A(2002) gene in fragile X syndrome Curr Opin Genet Dev 12 278-283
[4]  
Pieretti M(2004)The fragile X premutation: into the phenotypic fold JAMA 291 460-469
[5]  
Zhang FP(2000)Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population Am J Hum Genet 66 6-15
[6]  
Fu YH(2003)Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome Genet Test 7 339-343
[7]  
Hagerman RJ(1999)Incidence of fragile X in 5,000 consecutive newborn males Am J Hum Genet 65 98-103
[8]  
Hagerman PJ(2004)Noninvasive test for fragile X syndrome, using hair root analysis Am J Hum Genet 74 805-816
[9]  
Jacquemont S(2002)The fragile-X premutation: a maturing perspective Curr Opin Neurol 15 545-552
[10]  
Hagerman RJ(2002)Myotonic syndromes Brain 125 1760-1771